Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dalteparin versus unfractionated heparin for thromboprophylaxis in critically ill ICU patients
ACTRN12606000090516Phase 4Completed
- Sponsor
- McMaster University
- Start
- May 2006
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 5
01
Overview
Phase 4, randomised, double-blind trial in venous thromboembolism (VTE) comparing Dalteparin arm with Unfractionated heparin arm (2 arms). Primary endpoint: Proximal deep vein thrombosis. Started May 2006; status: completed.
02
Drugs
dalteparinheparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on ACTRN12606000090516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000090516.